Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2020-05-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$106.5m reported value -21.4% vs Q4 2019
18positions
93.0%in top 10
1 new 2 added 1 reduced 1 sold out vs Q4 2019

Holdings, Q1 2020

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 857,494 $29.2m27.41% 27.41% UnchangedShares held: Q4 2019 857.5k, Q1 2020 857.5k
2 CORBUS PHARMACEUTICALS HLDGS COM CRBP CRBP 5,045,870 $26.4m24.84% 24.84% UnchangedShares held: Q4 2019 5.0m, Q1 2020 5.0m
3 APPLIED THERAPEUTICS INC COM APLT APLT 642,071 $21.0m19.72% 19.72% AddedShares held: Q4 2019 467.1k, Q1 2020 642.1k +175.0k +175,000 37.5%
4 ABEONA THERAPEUTICS INC COM COM 2,859,767 $6.0m5.64% 5.64% UnchangedShares held: Q4 2019 2.9m, Q1 2020 2.9m
5 BLACKSTONE GROUP L P COM UNIT LTD BX BX 80,000 $3.6m3.42% 3.42% ReducedShares held: Q4 2019 153.0k, Q1 2020 80.0k -73.0k -73,000 -47.7%
6 ENTERA BIO LTD SHS ENTX ENTX 1,741,363 $3.3m3.08% 3.08% UnchangedShares held: Q4 2019 1.7m, Q1 2020 1.7m
7 EIGER BIOPHARMACEUTICALS INC COM CLDN CLDN 475,238 $3.2m3.04% 3.04% AddedShares held: Q4 2019 350.2k, Q1 2020 475.2k +125.0k +125,000 35.7%
8 ANAVEX LIFE SCIENCES CORP COM NEW AVXL AVXL 724,205 $2.3m2.14% 2.14% UnchangedShares held: Q4 2019 724.2k, Q1 2020 724.2k
9 CENTURYLINK INC COM CTL CTL 220,000 $2.1m1.95% 1.95% UnchangedShares held: Q4 2019 220.0k, Q1 2020 220.0k
10 EXICURE INC COM XCUR XCUR 1,277,777 $1.9m1.78% 1.78% UnchangedShares held: Q4 2019 1.3m, Q1 2020 1.3m
11 MOLECULAR TEMPLATES INC COM COM 113,905 $1.5m1.42% 1.42% UnchangedShares held: Q4 2019 113.9k, Q1 2020 113.9k
12 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 569,405 $1.4m1.32% 1.32% UnchangedShares held: Q4 2019 569.4k, Q1 2020 569.4k
13 SOLIGENIX INC COM COM 787,830 $1.3m1.24% 1.24% UnchangedShares held: Q4 2019 787.8k, Q1 2020 787.8k
14 DOW INC COM DOW DOW 30,000 $877.0k0.82% 0.82% UnchangedShares held: Q4 2019 30.0k, Q1 2020 30.0k
15 CORTEVA INC COM CTVA CTVA 30,000 $705.0k0.66% 0.66% UnchangedShares held: Q4 2019 30.0k, Q1 2020 30.0k
16 CATASYS INC COM PAR COM PAR 43,034 $655.0k0.62% 0.62% UnchangedShares held: Q4 2019 43.0k, Q1 2020 43.0k
17 DUPONT DE NEMOURS INC COM DWDP DWDP 15,000 $512.0k0.48% 0.48% UnchangedShares held: Q4 2019 15.0k, Q1 2020 15.0k
18 BIOXCEL THERAPEUTICS INC COM COM 20,000 $447.0k0.42% 0.42% NewShares held: Q4 2019 0, Q1 2020 20.0k

Sold out since Q4 2019

SecurityTickerShares held beforeValue then
KRANESHARES TR KBA KBA 96,000 $3.1m96.0k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08